Last reviewed · How we verify
NCT03196245: Flu vaccine
NK Cell Mediated Influenza Immunity During Pregnancy
trial testing There is no intervention. in Pregnancy Related in 94 participants. Terminated before completion.
1 April 2019
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 94 |
| Start date | 14 August 2012 |
| Primary completion | 1 April 2019 |
| Estimated completion | 1 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- There is no intervention.
Conditions studied
- Pregnancy Related — all drugs for Pregnancy Related →
- Influenza, Human — all drugs for Influenza, Human →
Sponsor
Stanford University
Who can join
Adults 18 to 45, female only, with Pregnancy Related or Influenza, Human. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pregnant women have increased morbidity and mortality due to infection with influenza. Changes in T cell function have been proposed as possible mechanisms for this finding. We believe that pregnancy induced changes in NK cell phenotype and function also impact influenza immunity. This study will compare the immune response of pregnant women and controls to TIV influenza vaccination as a surrogate for infection. In addition pregnant women with flu like illness will be enrolled to evaluate changes in immune response following influenza infection as compared to vaccination.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03196245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of There is no intervention.
Trials testing the same drug.
- NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
- NCT06113601 — Assessment of Admission to the ICU of Onco-hematological Patients. · unknown
- NCT06016309 — The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis · recruiting
- NCT06347445 — Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study) · completed
- NCT04804995 — Investigating the Frequency and Phenotype of Headaches Associated With Fasting During the Month of Ramadan. · completed
Other recruiting trials for Pregnancy Related
Currently open trials in the same condition.
- NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
- NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03196245 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 14 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03196245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing